Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $255416.0.

  • Stemtech's Cash & Equivalents fell 189.29% to $255416.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $255416.0, marking a year-over-year decrease of 189.29%. This contributed to the annual value of $255298.0 for FY2024, which is 12362.0% up from last year.
  • Stemtech's Cash & Equivalents amounted to $255416.0 in Q3 2025, which was down 189.29% from $272450.0 recorded in Q2 2025.
  • Over the past 5 years, Stemtech's Cash & Equivalents peaked at $1.6 million during Q3 2021, and registered a low of $114166.0 during Q4 2023.
  • Over the past 5 years, Stemtech's median Cash & Equivalents value was $273999.0 (recorded in 2024), while the average stood at $384748.8.
  • As far as peak fluctuations go, Stemtech's Cash & Equivalents soared by 137240.0% in 2021, and later plummeted by 9229.82% in 2022.
  • Stemtech's Cash & Equivalents (Quarter) stood at $828206.0 in 2021, then tumbled by 84.0% to $132487.0 in 2022, then fell by 13.83% to $114166.0 in 2023, then soared by 123.62% to $255298.0 in 2024, then rose by 0.05% to $255416.0 in 2025.
  • Its Cash & Equivalents was $255416.0 in Q3 2025, compared to $272450.0 in Q2 2025 and $305836.0 in Q1 2025.